73 related articles for article (PubMed ID: 33221516)
1. The Addition of Topotecan to Melphalan in the Treatment of Retinoblastoma with Intra-arterial Chemotherapy.
Stacey AW; De Francesco S; Borri M; Hadjistilianou T
Ophthalmol Retina; 2021 Aug; 5(8):824-830. PubMed ID: 33221516
[TBL] [Abstract][Full Text] [Related]
2. Angiographic characteristics and treatment approach in patients undergoing intra-arterial chemotherapy for retinoblastoma.
Rusakevich AM; Nahhas MI; Zhou B; Dannenbaum MJ; Bretana ME; Schefler AC
Graefes Arch Clin Exp Ophthalmol; 2024 Apr; 262(4):1321-1328. PubMed ID: 38032379
[TBL] [Abstract][Full Text] [Related]
3. Globe salvage treatment in group D and group E retinoblastoma.
Hussain AK; Rahul RA; Carlos RL; Francisco ZM; María GL; Flavia P; Chiara B; Davide B
Rom J Ophthalmol; 2021; 65(1):20-24. PubMed ID: 33817429
[No Abstract] [Full Text] [Related]
4. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients.
Bogan CM; Pierce JM; Doss SD; Tao YK; Chen SC; Boyd KL; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB
Exp Eye Res; 2021 Mar; 204():108439. PubMed ID: 33444583
[TBL] [Abstract][Full Text] [Related]
5. Advancements in super-selective catheterization and drug selection for intra-arterial chemotherapy for retinoblastoma: a 15-year evolution.
Kocharian G; Gobin YP; Kharas N; Knopman J; Francis JH; Abramson DH
J Neurointerv Surg; 2024 Mar; 16(4):398-404. PubMed ID: 37197934
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for cataract in retinoblastoma management.
Jia S; Wen X; Yu J; Zhou M; Yang L; Feng Y; He X; Jia R; Fan J; Fan X
Br J Ophthalmol; 2024 Mar; 108(4):571-577. PubMed ID: 37068919
[TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy.
Shields CL; Fulco EM; Arias JD; Alarcon C; Pellegrini M; Rishi P; Kaliki S; Bianciotto CG; Shields JA
Eye (Lond); 2013 Feb; 27(2):253-64. PubMed ID: 22995941
[TBL] [Abstract][Full Text] [Related]
8. Efficacy, Toxicity, and Pharmacokinetics of Intra-Arterial Chemotherapy Versus Intravenous Chemotherapy for Retinoblastoma in Animal Models and Patients.
Daniels AB; Froehler MT; Kaczmarek JV; Bogan CM; Santapuram PR; Pierce JM; Chen SC; Schremp EA; Boyd KL; Tao YK; Calcutt MW; Koyama T; Richmond A; Friedman DL
Transl Vis Sci Technol; 2021 Sep; 10(11):10. PubMed ID: 34495330
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of the efficacy of intra-arterial chemotherapy for the management of retinoblastoma patients.
Yu G; Zhou X; Li J
Adv Clin Exp Med; 2024 Mar; 33(3):207-216. PubMed ID: 37486698
[TBL] [Abstract][Full Text] [Related]
10. Conservative treatment using laser diode and systemic chemotherapy for early-stage bilateral retinoblastoma: A 14-year prospective cohort study.
Phan TAT; Derumigny A; Duong MC; Desjardins L; Cung TA; Nguyen CK
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1919. PubMed ID: 37849419
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal topotecan for vitreous seeds in retinoblastoma: A long-term review of 91 eyes.
Sen M; Rao R; Mulay K; Reddy VAP; Honavar SG
Ophthalmology; 2024 May; ():. PubMed ID: 38703794
[TBL] [Abstract][Full Text] [Related]
12. Retinoblastoma Outcomes in the Americas: A Prospective Analysis of 491 Children With Retinoblastoma From 23 American Countries.
Berry JL; Pike S; Rajagopalan A; Reid MW; Fabian ID;
Am J Ophthalmol; 2024 Apr; 260():91-101. PubMed ID: 37949286
[TBL] [Abstract][Full Text] [Related]
13. Less is more: new one-step intracameral chemotherapy technique.
Borroni D; Bonzano C; Rachwani-Anil R; Rocha-de Lossada C; Martín FZ; Garcia-Lorente M; Bonzano E; Khaqan HA
Rom J Ophthalmol; 2021; 65(3):218-221. PubMed ID: 35036640
[No Abstract] [Full Text] [Related]
14. Clinicodemographic profile, management, and treatment outcomes in advanced retinoblastoma at a tertiary care center in North India.
Kumar SV; Kumar V; Sati A; Mishra SK; Khera S; Mishra A; Mathur A; Gopinath M; Mohimen A; Malik V; Kumar NV
Indian J Ophthalmol; 2024 May; 72(5):653-658. PubMed ID: 38099390
[TBL] [Abstract][Full Text] [Related]
15. Amniotic Membrane Augmentation for Enucleation After Chemotherapy in Retinoblastoma.
Ramasubramanian A; Rehman NS; Chauhan A; Rodriguez A; Leverant A; Tiwari N
J Pediatr Ophthalmol Strabismus; 2024 Apr; ():1-6. PubMed ID: 38661308
[TBL] [Abstract][Full Text] [Related]
16. Preclinical validation of a novel therapeutic strategy for choroid plexus carcinoma.
Martin B; Garman T; Laramee M; Wang A; Zhang X; Beck E; Wilson K; Klumpp-Thomas C; McKnight C; Xu X; Hagen N; Holland D; Dahmane N; Thomas CJ; Souweidane M
J Control Release; 2023 May; 357():580-590. PubMed ID: 37054779
[TBL] [Abstract][Full Text] [Related]
17. Management of retinoblastoma: are we there yet?
Raval V; Singh A
Can J Ophthalmol; 2024 Feb; ():. PubMed ID: 38431272
[TBL] [Abstract][Full Text] [Related]
18. Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: a retrospective analysis of 96 consecutive pediatric interventions using five distinct protocols.
Monroe EJ; Chick JFB; Stacey AW; Millard NE; Geyer JR; Ramoso LR; Ghodke BV; Hallam DK
Pediatr Radiol; 2021 Apr; 51(4):649-657. PubMed ID: 33231717
[TBL] [Abstract][Full Text] [Related]
19. Painful Glaucoma and Pseudohypopyon in a Child with Retinoblastoma.
Calotti M; Yaghy A; Shields CL
Ophthalmol Glaucoma; 2020; 3(6):480. PubMed ID: 33243407
[No Abstract] [Full Text] [Related]
20. Next generation sequencing of RB1gene for the molecular diagnosis of ethnic minority with retinoblastoma in Yunnan.
Zhang Z; Xiao YS; Shen R; Jiang HC; Tan L; Li RQ; Yang XH; Gu HY; He WJ; Ma J
BMC Med Genet; 2020 Nov; 21(1):230. PubMed ID: 33225895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
